Full-Time

Senior Manager of Clinical Affairs

Neptune Medical

Neptune Medical

1-10 employees

At-home fertility diagnostics and non-invasive device

Compensation Overview

$182.5k - $229k/yr

+ Equity

Burlingame, CA, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
Google Cloud Platform
Requirements
  • B.S. in Biomedical Engineering, Life Sciences or similar
  • 7-10+ years of progressive experience in clinical research within the medical device industry, including leadership of complex clinical studies
  • Demonstrated experience developing and executing clinical strategies that support regulatory submissions and product approvals.
  • Strong working knowledge of Good Clinical Practice (GCP), FDA and international regulations, ISO standards and clinical research best practices
  • Proven ability to lead cross-functional teams and influence without direct authority.
  • Excellent written and verbal communication, skills including experience presenting to senior leadership and regulatory agencies
  • High attention to detail and accuracy
  • Fluent in medical terminology and sound knowledge of anatomy
  • Strong analytical, problem-solving, and decision-making skills with high professional judgment.
  • Ability to thrive in a fast-paced, evolving startup environment with a hands-on, ownership-oriented mindset
  • Takes initiative and acts quickly to drive to solutions with a driven outlook and with a strong desire to succeed as a team player, and as a key part of a company
  • Ability to travel up 20% domestically and internationally
Responsibilities
  • Lead the development and execution of the overall clinical strategy aligned with company and regulatory objectives.
  • Provide expert input into clinical development plans, trial design, and evidence-generation strategies across the product lifecycle.
  • Advise senior leadership on clinical risks, opportunities, and trade-offs.
  • Oversee the design, initiation, execution, monitoring, and closeout of clinical studies, ensuring adherence to timelines, budgets, and quality standards.
  • Provide strategic oversight of CROs, vendors, investigators, and internal teams to ensure effective study conduct.
  • Establish and monitor study performance metrics; proactively identify risks and lead cross-functional mitigation strategies.
  • Participate in the development of clinical strategy and trial design.
  • Lead the development and review of key clinical documents, including protocols, amendments, investigator brochures, informed consent forms, case report forms, and clinical study reports.
  • Interpret and synthesize clinical, scientific, and risk data to support regulatory submissions, scientific publications, and labeling claims.
  • Facilitate regulatory submissions and communications. Interacts with regulatory agencies as needed and use scientific and medical knowledge to write strategic responses to questions from regulatory bodies about submissions.
  • Provide oversight of clinical data review, including safety and adverse event evaluation, throughout study conduct and reporting.
  • Ensure clinical activities are conducted in compliance with GCP, FDA, ISO, and applicable international regulations.
  • Partner with Quality to develop and implement SOPs, support audits, complaint review, and implementation of corrective and preventive actions.
  • Provide strategic oversight of clinical trial budgets, timelines, and resource planning.
  • Lead or oversee contract negotiations with investigators, institutions, CROs, and other vendors.
  • Drive continuous improvement of clinical processes, systems, and best practices
Desired Qualifications
  • Experience in medical robotics
  • Master’s degree or higher in Biomedical Engineering, Life Sciences, or a related discipline
  • Experience or knowledge of the GI/endoscopy space

Neptune Medical develops devices and tests to address male infertility. Its two main products are Pro-Test, an at-home diagnostic kit that lets individuals test fertility parameters from home, and Neptune, a non-invasive device designed to improve sperm quality. Pro-Test provides a convenient way to assess fertility without clinic visits, while Neptune uses a proprietary, non-invasive method to enhance key sperm metrics and is intended for home use alongside clinical fertility treatment. The company serves both clinics (B2B) and individual consumers (B2C) and markets its products to help diagnose and treat male infertility, a factor in about half of all infertility cases. Neptune Medical differentiates itself by offering integrated, consumer-accessible diagnostics and treatment tools, backed by grant funding and participation in precision medicine programs, aiming to make diagnosis and treatment more private, accessible, and effective.

Company Size

1-10

Company Stage

Series D

Total Funding

$97M

Headquarters

Burlingame, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Varicocele embolization boosts sperm parameters, complementing Neptune's enhancement device.
  • E-cigarette harm awareness drives Pro-Test demand for lifestyle-impacted diagnostics.
  • Innovate UK and Horizon 2020 grants validate clinical innovation for market entry.

What critics are saying

  • Varicocele embolization by University Radiology eliminates Neptune device need in 12-24 months.
  • RSC New Jersey clinics integrate evaluations, cutting Pro-Test demand in 6-18 months.
  • Clomiphene citrate adoption by urologists cannibalizes device market in 12-24 months.

What makes Neptune Medical unique

  • Pro-Test delivers at-home male fertility diagnostics for convenient sperm analysis.
  • Neptune device non-invasively enhances sperm quality via patented home-use technology.
  • Targets male infertility gap, serving B2B clinics and B2C consumers since 2018.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Neptune Medical who can refer or advise you

Benefits

401(k) Company Match

Company Equity

Company News

The Robot Report
Oct 4th, 2024
Robotics Investments Near $1B In August

Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies

Business Wire
Aug 17th, 2024
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.